H. Sugimoto, M. Muto, T. Tanaka, A. Osuka
FULL PAPER
H, BODIPY-H), 2.70 (s, 18 H, Me), 0.92 (s, 3 H, OMe) ppm. 11B
NMR (193 MHz, CDCl3): δ = 0.98 (t, J = 66.0 Hz, 3 B, BODIPY),
–15.06 (s, 1 B, subporphyrin) ppm. 13C NMR (150 MHz, CDCl3):
δ = 158.7, 143.1, 143.0, 141.8, 140.3, 137.8, 135.3, 134.6, 134.3,
132.0, 131.2, 128.2, 127.7, 123.2, 120.9, 120.2, 47.2, 15.1 ppm.
HRMS (ESI-TOF+): m/z = 1352.5293 (calcd. for C84H60B4F6N9
1352.5284 [M – OMe]+). UV/Vis (CH2Cl2): λ (ε, m–1 cm–1) = 382
(127000), 512 (79000) nm. Fluorescence (CH2Cl2) λex = 383 nm,
cence (CH2Cl2): λex = 390 nm, λmax = 535 nm, ΦF = 0.013, λex
513 nm, λmax = 535 nm, ΦF = 0.013.
=
Methoxido[5,10,15-tris(4-biphenylyl)subporphyrinato]boron(III) (14):
A 10-mL Schlenk tube was charged with 5,10,15-tris(4-bro-
mophenyl)subporphyrin
methyl-2-phenyl-1,3,2-dioxaborolane
5
(19.2 mg, 26.0 μmol), 4,4,5,5-tetra-
(24.4 mg, 119 μmol),
Pd(dppf)Cl2·CH2Cl2 (4.57 mg, 5.60 μmol), K2CO3 (118 mg,
857 μmol), toluene (1.8 mL), and H2O (0.3 mL). The resulting solu-
tion was deoxygenated through three freeze–pump–thaw cycles and
then stirred at 100 °C for 6 h under a N2 atmosphere. After the
mixture was passed through a short Celite pad, the mixture was
diluted with CHCl3. The resulting solution was washed with water
and brine, and the solvents were evaporated to dryness. To the re-
sidual solid, a mixture of CHCl3/MeOH (1:1, 50 mL) was added,
and the solution was heated at 50 °C for 10 min. The product was
separated through a silica gel column (CH2Cl2/hexane/MeOH,
2:10:1) and recrystallized (CH2Cl2/MeOH) to give 14 (13.5 mg,
18.6 μmol, 71% yield) as a red powder. 1H NMR (600 MHz,
CDCl3): δ = 8.22 (s, 6 H, β-H), 8.18 (d, J = 8.2 Hz, 6 H, Ar-H),
7.95 (d, J = 8.2 Hz, 6 H, Ar-H), 7.81 (d, J = 7.3 Hz, 6 H, Ar-H),
7.55 (t, J = 7.8 Hz, 6 H, Ar-H), 7.44 (t, J = 7.2 Hz, 3 H, Ar-H),
0.89 (s, 3 H, OMe) ppm. 11B NMR (193 MHz, CDCl3): δ = –15.11
(s, 1 B) ppm. 13C NMR (150 MHz, CDCl3): δ = 141.1, 140.8, 136.4,
133.8, 129.1, 127.8, 127.5, 127.4, 122.7, 122.5, 120.3, 47.0 ppm.
HRMS (ESI-TOF+): m/z = 698.2770 (calcd. for C51H33BN3
698.2770 [M – OMe]+). UV/Vis (CH2Cl2): λ (ε, m–1 cm–1) = 382
(163000), 468 (13000), 495 (17000) nm. Fluorescence (CH2Cl2): λex
= 382 nm, λmax = 548 nm, ΦF = 0.255.
λmax = 530 nm, ΦF = 0.007, λex = 512 nm, λmax = 530 nm, ΦF
=
0.010.
BODIPY-Appended Subporphyrin 3:
A 10-mL Schlenk tube
was charged with 5,10,15-tris(4-ethynylphenyl)subporphyrin 10
(10.6 mg, 18.5 μmol), BODIPY 11 (26.6 mg, 59.2 μmol), Pd(PPh3)2-
Cl2 (4.3 mg, 3.70 μmol), CuI (1.4 mg, 7.40 μmol), toluene (0.8 mL),
and diisopropylamine (0.8 mL). The resulting solution was deoxy-
genated through three freeze–pump–thaw cycles and then stirred at
80 °C for 21 h under a N2 atmosphere. After the mixture was
passed through a short Celite pad, the mixture was diluted with
CH2Cl2 (50 mL). The resulting solution was washed with water and
brine, and the solvents were evaporated to dryness. To the residual
solid, a mixture of CH2Cl2/MeOH (1:1, 50 mL) was added, and the
solution was heated at 50 °C for 10 min. The product was separated
through a silica gel column (CH2Cl2/hexane/ether, 1:2:1) and
recrystallized (CH2Cl2/MeOH) to give 3 (19.8 mg, 12.9 μmol, 70%
yield) as an orange powder. 1H NMR (600 MHz, CDCl3): δ = 8.18
(s, 6 H, β-H), 8.11 (d, J = 7.8 Hz, 6 H, Ar-H), 7.91 (d, J = 8.4 Hz,
6 H, Ar-H), 7.77 (d, J = 7.2 Hz, 6 H, Ar-H), 7.36 (d, J = 7.2 Hz,
6 H, Ar-H), 6.02 (s, 6 H, BODIPY-H), 2.58 (s, 18 H, Me), 1.49 (s,
18 H, Me), 0.86 (s, 3 H, OMe) ppm. 11B NMR (193 MHz, CDCl3):
δ = 0.75 (t, J = 33.9 Hz, 3 B, BODIPY), –15.20 (s, 1 B, subporphy-
rin) ppm. 13C NMR (150 MHz, CDCl3): δ = 155.8, 143.0, 140.8,
140.7, 137.4, 135.2, 133.2, 132.4, 132.0, 131.2, 128.3, 124.0, 122.5,
122.4, 121.4, 120.0, 90.5, 90.2, 46.8, 29.7, 14.7 ppm. HRMS (ESI-
TOF+): m/z = 1508.6159 (calcd. for C90H72B4F6N9 1508.6227 [M –
OMe]+). UV/Vis (CH2Cl2): λ (ε, m–1 cm–1) = 389 (155000), 502
(104000) nm. Fluorescence (CH2Cl2): λex = 389 nm, λmax = 548 nm,
ΦF = 0.363, λex = 502 nm, λmax = 548 nm, ΦF = 0.297.
Methoxido[5,10,15-tris(4-terphenylyl)subporphyrinato]boron(III)
(15): A 10-mL Schlenk tube was charged with 5,10,15-tris(4-bro-
mophenyl)subporphyrin
5 (19.2 mg, 26.0 μmol), 4-(4,4,5,5-tet-
ramethyl-1,3,2-dioxaborolan-2-yl)biphenyl (31.9 mg, 114 μmol),
Pd(dppf)Cl2·CH2Cl2 (4.34 mg, 5.31 μmol), K2CO3 (121 mg,
878 μmol), toluene (1.3 mL), and H2O (0.3 mL). The resulting solu-
tion was deoxygenated through three freeze–pump–thaw cycles and
then stirred at 100 °C for 9 h under a N2 atmosphere. After the
mixture was passed through a short Celite pad, the mixture was
diluted with CHCl3. The resulting solution was washed with water
and brine, and the solvents were evaporated to dryness. To the re-
sidual solid, a mixture of CHCl3/MeOH (1:1, 50 mL) was added,
and the solution was heated at 50 °C for 10 min. The product was
separated through a silica gel column (CH2Cl2/hexane/MeOH,
2:10:1) and recrystallized (CH2Cl2/MeOH) to give 15 (19.1 mg,
19.9 μmol, 77% yield) as a red powder. 1H NMR (600 MHz,
CDCl3): δ = 8.24 (s, 6 H, β-H), 8.20 (d, J = 8.2 Hz, 6 H, Ar-H),
8.01 (d, J = 7.8 Hz, 6 H, Ar-H), 7.90 (d, J = 8.2 Hz, 6 H, Ar-H),
7.79 (d, J = 8.3 Hz, 6 H, Ar-H), 7.72 (d, J = 7.3 Hz, 3 H, Ar-
H),7.51 (t, J = 7.8 Hz, 6 H, Ar-H), 7.40 (t, J = 7.8 Hz, 3 H, Ar-
H), 0.91 (s, 3 H, OMe) ppm. 11B NMR (193 MHz, CDCl3): δ =
–15.08 (s, 1 B) ppm. 13C NMR (150 MHz, CDCl3): δ = 141.1,
140.8, 140.7,140.2, 139.6, 136.5, 133.8, 129.0, 127.9, 127.8, 127.7,
127.6, 127.4, 127.2, 122.5, 120.4, 47.1 ppm. HRMS (ESI-TOF+):
m/z = 926.3703 (calcd. for C69H45BN3 926.3712 [M – OMe]+). UV/
Vis (CH2Cl2): λ (ε, m–1 cm–1) = 385 (223000), 497(25000) nm. Fluo-
rescence (CH2Cl2): λex = 385 nm, λmax = 548 nm, ΦF = 0.337.
BODIPY-Appended Subporphyrin 4: A 10-mL Schlenk tube was
charged with 5,10,15-tris(4-ethynylphenyl)subporphyrin 10
(12.0 mg, 20.9 μmol), BODIPY 12 (29.1 mg, 69.0 μmol), Pd(PPh3)2-
Cl2 (4.8 mg, 4.18 μmol), CuI (1.6 mg, 8.36 μmol), toluene (0.8 mL),
and diisopropylamine (0.8 mL). The resulting solution was deoxy-
genated through three freeze–pump–thaw cycles and then stirred at
80 °C for 21 h under a N2 atmosphere. After the mixture was
passed through a short Celite pad, the mixture was diluted with
CH2Cl2 (50 mL). The resulting solution was washed with water and
brine, and the solvents were evaporated to dryness. To the residual
solid, a mixture of CH2Cl2/MeOH (1:1, 50 mL) was added, and the
solution was heated at 50 °C for 10 min. The product was separated
through a silica gel column (CH2Cl2/hexane/ether, 1:2:1) and
recrystallized (CH2Cl2/MeOH) to give 4 (22.1 mg, 15.2 μmol, 73%
1
yield) as a red powder. H NMR (600 MHz, CDCl3): δ = 8.19 (s,
6 H, β-H), 8.12 (d, J = 9.0 Hz, 6 H, Ar-H), 7.92 (d, J = 7.8 Hz, 6
H, Ar-H), 7.74 (d, J = 7.8 Hz, 6 H, Ar-H), 7.56 (d, J = 8.4 Hz, 6
H, Ar-H), 6.77 (d, J = 4.2 Hz, 6 H, BODIPY-H), 6.31 (d, J =
4.2 Hz, 6 H, BODIPY-H), 2.68 (s, 18 H, Me), 0.87 (s, 3 H,
OMe) ppm. 11B NMR (193 MHz, CDCl3): δ = 0.93 (t, J = 32.4 Hz,
3 B, BODIPY), –15.20 (s, 1 B, subporphyrin) ppm. 13C NMR
(150 MHz, CDCl3): δ = 157.9, 141.5, 143.0, 140.9, 137.5, 134.3,
134.2, 133.2, 132.0, 131.5, 130.5, 130.2, 125.1, 122.5, 122.4, 119.6,
91.3, 90.2, 46.9, 15.0 ppm. HRMS (ESI-TOF+) m/z = 1424.5299
Crystallographic Data for 1: C91H75B4F6N9O1, M = 1467.84, tri-
¯
clinic, space group P1 (no. 2), a = 9.086(8) Å, b = 23.79(2) Å, c =
24.84(2) Å, α = 97.060(12)°, β = 95.959(13)°, γ = 93.029(14)°, V =
5288(8) Å3, ρcalcd. = 0.922 gcm–3, Z = 2, R1 = 0.1018 [I Ͼ 2σ(I)],
wR2 = 0.2323 (all data), GOF = 0.709.
The contributions to the scattering arising from the presence of the
disordered solvents in the crystals were removed by use of the util-
ity SQUEEZE in the PLATON software package.[14]
(calcd. for C84H60B4F6N9 1424.5286 [M
–
OMe]+). UV/Vis
(CH2Cl2): λ (ε, m–1 cm–1) = 390 (138000), 513 (121000) nm. Fluores-
76
www.eurjoc.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2011, 71–77